A detailed history of Advisor Group Holdings, Inc. transactions in Procept Bio Robotics Corp stock. As of the latest transaction made, Advisor Group Holdings, Inc. holds 939 shares of PRCT stock, worth $87,890. This represents 0.0% of its overall portfolio holdings.

Number of Shares
939
Previous 909 3.3%
Holding current value
$87,890
Previous $55,000 36.36%
% of portfolio
0.0%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$56.31 - $84.99 $1,689 - $2,549
30 Added 3.3%
939 $75,000
Q2 2024

Aug 13, 2024

SELL
$45.73 - $69.19 $438,779 - $663,878
-9,595 Reduced 91.35%
909 $55,000
Q1 2024

May 10, 2024

BUY
$40.38 - $50.75 $402,184 - $505,470
9,960 Added 1830.88%
10,504 $519,000
Q4 2023

Feb 12, 2024

SELL
$24.89 - $43.41 $7,840 - $13,674
-315 Reduced 36.67%
544 $22,000
Q3 2023

Nov 13, 2023

SELL
$30.02 - $38.81 $17,141 - $22,160
-571 Reduced 39.93%
859 $28,000
Q2 2023

Aug 10, 2023

BUY
$26.7 - $37.02 $9,024 - $12,512
338 Added 30.95%
1,430 $50,000
Q1 2023

May 12, 2023

SELL
$26.64 - $39.74 $1,438 - $2,145
-54 Reduced 4.71%
1,092 $31,000
Q4 2022

Feb 10, 2023

SELL
$38.78 - $46.78 $760,747 - $917,683
-19,617 Reduced 94.48%
1,146 $47,000
Q3 2022

Nov 14, 2022

SELL
$30.9 - $50.65 $249,733 - $409,353
-8,082 Reduced 28.02%
20,763 $861,000
Q2 2022

Aug 10, 2022

SELL
$29.23 - $44.45 $135,831 - $206,559
-4,647 Reduced 13.87%
28,845 $943,000
Q1 2022

May 04, 2022

BUY
$16.89 - $35.74 $558,923 - $1.18 Million
33,092 Added 8273.0%
33,492 $1.17 Million
Q3 2021

Nov 05, 2021

BUY
$35.91 - $41.94 $14,363 - $16,776
400 New
400 $15,000

Others Institutions Holding PRCT

About PROCEPT BioRobotics Corp


  • Ticker PRCT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 44,592,300
  • Market Cap $4.17B
  • Description
  • PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally-invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). The company also designs Aqu...
More about PRCT
Track This Portfolio

Track Advisor Group Holdings, Inc. Portfolio

Follow Advisor Group Holdings, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Advisor Group Holdings, Inc. with notifications on news.